These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21930830)

  • 1. Management of anemia in cancer patients: transfusions.
    Schrijvers D
    Oncologist; 2011; 16 Suppl 3():12-8. PubMed ID: 21930830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer.
    Panagopoulos ND; Karakantza M; Koletsis E; Apostolakis E; Sakellaropoulos GC; Filos KS; Eleni T; Dougenis D
    Lung Cancer; 2008 Nov; 62(2):273-80. PubMed ID: 18430486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice and costs of red blood cell (RBC) transfusion in an oncological unit.
    Norum J; Moen MA
    Anticancer Res; 2008; 28(1B):459-64. PubMed ID: 18383885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient blood transfusion management: discharge hemoglobin level as a surrogate marker for red blood cell utilization appropriateness.
    Edwards J; Morrison C; Mohiuddin M; Tchatalbachev V; Patel C; Schwickerath VL; Menitove JE; Singh G
    Transfusion; 2012 Nov; 52(11):2445-51. PubMed ID: 22413968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion.
    Glenngård AH; Persson U; Söderman C
    Transfus Med; 2005 Aug; 15(4):295-306. PubMed ID: 16101807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood management in intensive care medicine: CRIT and ABC--what can we learn?
    Spahn DR; Marcucci C
    Crit Care; 2004 Apr; 8(2):89-90. PubMed ID: 15025763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five drivers shifting the paradigm from product-focused transfusion practice to patient blood management.
    Hofmann A; Farmer S; Shander A
    Oncologist; 2011; 16 Suppl 3():3-11. PubMed ID: 21930829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
    Nowrousian MR
    Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks, benefits, alternatives and indications of allogenic blood transfusions.
    Madjdpour C; Heindl V; Spahn DR
    Minerva Anestesiol; 2006 May; 72(5):283-98. PubMed ID: 16675937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL.
    Gilbertson DT; Monda KL; Bradbury BD; Collins AJ
    Am J Kidney Dis; 2013 Nov; 62(5):919-28. PubMed ID: 23815986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia and perioperative red blood cell transfusion: a matter of tolerance.
    Madjdpour C; Spahn DR; Weiskopf RB
    Crit Care Med; 2006 May; 34(5 Suppl):S102-8. PubMed ID: 16617252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes.
    Platzbecker U; Hofbauer LC; Ehninger G; Hölig K
    Leuk Res; 2012 May; 36(5):525-36. PubMed ID: 22300879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.
    Jabbour E; Kantarjian HM; Koller C; Taher A
    Cancer; 2008 Mar; 112(5):1089-95. PubMed ID: 18186499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.
    Quirt I; Kovacs M; Couture F; Turner AR; Noble M; Burkes R; Dolan S; Plante RK; Lau CY; Chang J
    Oncologist; 2006 Jan; 11(1):73-82. PubMed ID: 16401716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective review of blood transfusions in cancer patients with anemia.
    Estrin JT; Schocket L; Kregenow R; Henry DH
    Oncologist; 1999; 4(4):318-24. PubMed ID: 10476543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia management program reduces transfusion volumes, incidence of ventilator-associated pneumonia, and cost in trauma patients.
    Earley AS; Gracias VH; Haut E; Sicoutris CP; Wiebe DJ; Reilly PM; Schwab CW
    J Trauma; 2006 Jul; 61(1):1-5; discussion 5-7. PubMed ID: 16832243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
    Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.
    Hensley ML; Lebeau D; Leon LF; Venkatraman E; Waltzman R; Sabbatini P; Almadrones L; Chi D; Spriggs D
    Gynecol Oncol; 2001 Jun; 81(3):485-9. PubMed ID: 11371143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transfusion of recuperated blood in total knee arthroplasty].
    Pitsaer E
    Rev Chir Orthop Reparatrice Appar Mot; 2002 Dec; 88(8):777-89. PubMed ID: 12503019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.